UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)  May 22, 2007

KMG Chemicals, Inc.

(Exact name of registrant as specified in its charter)

TEXAS

 

000-29278

 

75-2640529

(State or other jurisdiction

 

(Commission

 

(IRS Employer

of incorporation)

 

File Number)

 

Identification No.)

 

 

 

 

 

10611 Harwin Drive, Suite 402, Houston, Texas

 

77036

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code  713-600-3800


(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



Item 5.02(d)  Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers

On May 22, 2007, the Board of Directors of KMG Chemicals, Inc., voted to increase the number of directors and appoint
Stephen A. Thorington to fill the additional position on the Board.  His term will expire at the Annual Stockholders Meeting in 2007.  There are no understandings or arrangements between Mr. Thorington and any other person by which he was selected as a director.  Mr. Thorington was appointed to the Audit Committee and the Nominating and Corporate Governance Committee of the Board.

A copy of the Press Release issued by the Company on May 22, 2007 is included as Exhibit 99.1 to this report on Form 8-K.

Item 9.01  Financial Statements and Exhibits

Exhibit Number

 

Exhibit

 

 

 

99.1

 

Press Release dated May 22, 2007

 

2



SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

KMG Chemicals, Inc.

 

By:

 /s/ John V. Sobchak

 

Date: May 23, 2007

 

John V. Sobchak,

 

 

Chief Financial Officer

 

 

3